Twitter Logo Youtube Circle Icon LinkedIn Icon

United States > Dispute resolution > Product liability, mass tort and class action: pharmaceuticals and medical devices - plaintiff > Law firm and leading lawyer rankings

Editorial

Index of tables

  1. Product liability, mass tort and class action: pharmaceuticals and medical devices - plaintiff
  2. Hall of Fame
  3. Leading lawyers

Leading lawyers

  1. 1
    • Andy Birchfield - Beasley, Allen, Crow, Methvin, Portis & Miles, P.C.
    • Russ Herman - Herman, Herman & Katz LLC
    • Seth Katz - Burg Simpson Eldredge Hersh & Jardine, P.C.
    • Mike Papantonio - Levin Papantonio Thomas Mitchell Rafferty & Proctor, P.A.
    • Michelle Parfitt - Ashcraft & Gerel LLP
    • Christopher Seeger - Seeger Weiss LLP

Who Represents Who

Find out which law firms are representing which Product liability, mass tort and class action: pharmaceuticals and medical devices - plaintiff clients in United States using The Legal 500's new comprehensive database of law firm/client relationships. Instantly search over 925,000 relationships, including over 83,000 Fortune 500, 46,000 FTSE350 and 13,000 DAX 30 relationships globally. Access is free for in-house lawyers, and by subscription for law firms. For more information, contact david.burgess@legal500.com.

CLICK HERE TO VISIT THE WHO REPRESENTS WHO SITE

Burg Simpson Eldredge Hersh & Jardine, P.C. has a strong track record representing plaintiffs in mass torts and MDLs in the pharmaceuticals and medical devices sector. The practice is jointly led by Kerry Jardine, Peter Burg and founding partner Michael Burg; Seth Katz and Cincinnati-based Janet Abaray co-head the firm’s mass tort group. Katz continues to act for the plaintiffs’ executive committee in several testosterone replacement therapy (TRT) lawsuits, involving high-profile TRT products, such as Testim and Axiron. Katz also defends the plaintiff side in proton pump inhibitor (PPI) cases, which were recently transferred to New Jersey and consolidated into an MDL. Other recent work includes acting for plaintiffs across the country in various hip implant product liability lawsuits. Meghan Quinlivan and Scott Eldredge are other key figures; all named partners are based in Denver, unless otherwise noted.

Trusted Advisor - with Finnegan

IP specialist Finnegan detail how their collaborative approach makes for a unique culture which is designed to allow them to work with clients in a way which is cognizant of the challenges facing all companies today.

Herman, Herman & Katz LLC regularly takes a leading role in the representation of plaintiffs in high-profile lawsuits in the pharmaceuticals and medical devices sectors, and is ‘one of the most respected mass tort and class action plaintiff firms with a national representation’. In one recent highlight, Stephen Herman and Soren Gisleson obtained a $4.5m settlement in a consumer protection claim against Teva Pharmaceuticals, involving alleged defects in anti-depressant Budeprion. In other work, Leonard Davis, James Klick and of counsel Joseph Kott continue to represent plaintiffs in claims against numerous defendants, in connection with allegedly defectively designed hip implants. The team is also part of the plaintiffs’ steering committees of the Fosamax and Granuflo MDLs. Herman, Davis and Russ Herman are ‘knowledgeable advocates with superb leadership abilities’; all named partners are based in New Orleans.

Levin Papantonio Thomas Mitchell Rafferty & Proctor, P.A. has vast experience with representing plaintiffs in nationwide product liability litigation related to pharmaceuticals and medical devices. Jeff Gaddy continues to act as counsel to the plaintiff side in litigation against manufacturers and distributors of opioids. In other work, the team acts as lead counsel for plaintiffs in a product liability lawsuit brought against Johnson & Johnson subsidiary Janssen Pharmaceuticals, involving claims that the labeling on blood thinner Xarelto is inadequate. The practice also handles hernia mesh lawsuits and claims brought against DePuy, which allege that the medical device Attune Knee is defectively designed. Key figures in the department include Troy Rafferty and Mike Papantonio; the practice is based in Pensacola, Florida.

The department at Lieff Cabraser Heimann & Bernstein, LLP is headed by Elizabeth Cabraser and regularly handles plaintiff-side work in high-profile pharmaceuticals and medical devices-related product liability litigation. In one highlight, Lexi Hazam acted for the plaintiffs’ steering committee in litigation against Daichii Sankyo and Forest Laboratories, involving injury claims related to the prescription blood pressure medication Benicar; a $300m settlement was reached in August 2017. Hazam also continues to represent plaintiffs in the ongoing Abilify personal injury lawsuits; Wendy Fleishman and Robert Nelson handle litigation related to DePuy’s ASR hip implants. All named partners are based in San Francisco, unless otherwise specified.

The Lanier Law Firm represents plaintiffs in pharmaceutical liability litigation and handles product liability, personal injury and medical malpractice claims. Led by W Mark Lanier in Houston, the team obtained a $247m verdict in a lawsuit against Johnson & Johnson and DePuy, on behalf of six people who suffered serious medical complications caused by defectively designed hip implants. The firm also represents plaintiffs in other medical device litigation, such as hip replacement Stryker Rejuvenate, hernia mesh cases and DePuy’s Attune Knee. In the pharmaceuticals area, the team handles litigation related to testosterone therapy drugs, talc powder and blood thinner Xarelto. Richard Meadow in Houston is another key figure.

The ‘excellent and well-respected’ department at Seeger Weiss LLP represents plaintiffs in class actions and mass torts in the pharmaceuticals and medical devices industry. David Buchanan continues to act as lead trial counsel in an ongoing class action against Roche, in which plaintiffs allege that acne medication Accutane caused them to develop Crohn’s disease; recently, Buchanan successfully revived more than 2,000 related cases. In another highlight, the team won a second bellwether trial as lead trial counsel for the plaintiff against AbbVie, involving testosterone replacement therapy drug AndroGel. Co-founders Stephen Weiss and ‘superb trial attorney’ Christopher Seeger are other key contacts in the department. All named partners are based in New York City.

The personal injury experts at Ashcraft & Gerel LLP handle medical product liability lawsuits related to unsafe drugs, implants and other devices. Michelle Parfitt continues to act as co-lead counsel in personal injury and wrongful death claims in In re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation, against J&J and its primary talc supplier Imerys. Christopher Tisi and James Green are also active in the department, which is based in Washington DC.

Montgomery-based Beasley, Allen, Crow, Methvin, Portis & Miles, P.C. handles medical devices and drug litigation. Leigh O’Dell continues to act as co-lead counsel in an MDL against Johnson & Johnson, in which plaintiffs allege that talc products cause ovarian cancer. Atlanta-based Navan Ward handles lawsuits related to defectively designed hip replacements and Andy Birchfield heads the firm’s mass tort department. Danielle Mason and Frank Woodson are other key figures.

Levin Sedran & Berman is headquartered in Philadelphia and regularly represents plaintiffs in pharmaceutical and medical devices-related lawsuits, arising from personal injury and defective product claims. In one recent highlight, Michael Weinkowitz and Frederick Longer successfully tried a Xarelto case to verdict, obtaining a total of nearly $28m in damages for plaintiff Lynn Hartman. Weinkowitz is also part of the plaintiff negotiation committee of the product liability litigation related to Bayer’s birth control pills Yaz, Yasmin and Ocella, in which a $56.9m settlement was reached.

Simmons Hanly Conroy’s department is jointly headed by John Simmons and Michael Angelides in Alton, and Paul Hanly and Jayne Conroy in New York. Conroy is a member of the plaintiffs’ executive committee for the DePuy Pinnacle MDL, in which plaintiffs claim to have suffered serious injuries from the hip replacements manufactured by Johnson & Johnson. In other work, Conroy and Alton-based John Foley serve on the plaintiffs’ steering committee for several MDLs related to transvaginal mesh litigation. Led by Trent Miracle, also based in Alton, the team represents hundreds of men injured by testosterone replacement therapy products, as one of three co-lead counsels.

International comparative guides

Giving the in-house community greater insight to the law and regulations in different jurisdictions.

Select Practice Area

Press releases

The latest news direct from law firms. If you would like to submit press releases for your firm, send an email request to

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to
  • BRIBERY ALLEGATIONS IN MORE THAN ONE JURISDICTION: THE IMPORTANCE OF ENSURING A JOINED-UP DEFENCE AP

    Aziz Rahman considers the Ericsson bribery investigation and outlines how best to respond if you are investigated by more than one law enforcement agency
  • Sulphur Cap Ahead - Regulatory

    Sulphur Cap Ahead - Regulatory
  • GTDT Shipping - India

    Mr Shardul Thacker heads the shipping, oil and gas and banking practice group at Mulla & Mulla & Craigie Blunt & Caroe. Lloyd’s List ranked him third in their top 10 lawyers stating: “Highly regarded for his work in the liquefied natural gas sector, particularly for interesting and highly geared finance deals in relation to infrastructure projects, energy, ports and ships.” india_-_gtdt_shipping_
  • BVI'S NEW ECONOMIC SUBSTANCE LEGISLATION

    The British Virgin Islands are rushing to pass by the end of December the new economic substance legislation to avoid the EU’s blacklist of tax haven jurisdictions.
  • Chambers Guides - Insurance 2018 - India

    India is a common-law jurisdiction. In general, Indian laws borrow heavily from, and are based on, English law. However, insurance law in India has certain unique features that deviate from English insurance law. The primary legislation of insurance law in India is the Insurance Act, 1938 (the “Insurance Act”) and the Insurance Rules, 1939 (the “Insurance Rules”).
  • AVELLUM advised largest Ukrainian brick manufacturer on restructuring and refinancing of its debt

    AVELLUM acted as the Ukrainian legal counsel to Private Joint Stock Company with Foreign Investments “Slobozhanska Budivelna Keramika” (“SBK ”) in connection with the restructuring and refinancing of SBK’s debt, valued at approximately EUR20 million. Atlas Advisors, an independent investment banking firm, acted as the exclusive financial advisor to the SBK’s shareholders in connection with the restructuring of the credit portfolio, attraction of financing for the debt’s refinancing, and buy-out of SBK’s shares.
  • AVELLUM advises on Ukraine’s USD2 billion Eurobond issue

    AVELLUM acted as the Ukrainian legal counsel to the Ministry of Finance of Ukraine on the USD2 billion sovereign Eurobond issue consisting of two tranches with 5.5 and 10-year tenor. J.P. Morgan Securities, Goldman Sachs, BNP Paribas, and Citigroup acted as joint lead managers on the transaction.
  • New Anti-Money Laundering Law

    The new anti-money laundering ( AML ) law of the UAE took effect at the end of October 2018. Containing features recommended by the Financial Action Task Force ( FATF ), the new law introduces subtle but important changes to the AML landscape in the UAE. 
  • Confidentiality Under Renewed Focus

    The UAE federal government has recently issued a raft of important legislation, addressing and in many ways updating areas of law that are key to businesses in the jurisdiction. Amongst this legislation is Federal Decree-Law 14 of 2018 concerning the central bank and the organisation of financial institutions and activities (the New Banking Law ) and Federal Decree-Law 20 of 2018 concerning anti-money laundering and anti-terrorism financing (the New AML Law ). Both the New Banking Law and the New AML Law repeal and replace the previous legislation on their respective subjects. Importantly, the New Banking Law and the New AML Law have together enhanced the protection afforded to confidential information under UAE law, in particular where financial and legal service providers and their customers and clients are concerned. 
  • Israel Chapter in The Virtual Currency Regulation Review

    Earlier this year, the Israel Tax Authority (ITA) issued two circulars, one on the taxation of digital tokens and the second addressing the taxation of utility tokens in initial coin offerings (ICOs). Additionally, in March, the Israel Securities Authority (ISA) released a detailed interim report by the Committee for the Regulation of Public Offerings of Decentralized Cryptocurrency Coins (Report) (with a follow-up report due to come out around October 2018). Moreover, it is expected that before the end of 2018, legislation will come into force that for the first time will see Israeli primary legislation define virtual currencies as financial assets and mandate licensing for related services, as is later discussed in detail.

Press Releases worldwide

The latest news direct from law firms. If you would like to submit press releases for your firm, send an email request to